SCHEMBL4192945

SCHEMBL4192945

CC(=O)Nc1nc2ccc(S(=O)(=O)Nc3ccccc3CNC(C)CC3CCCCC3)cc2s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
POLB P06746 1/20 0.47
CLK1 P49759 1/20 0.46
AKT1 P31749 9/20 0.45
PIK3CA P42336 8/20 0.45
HPGD P15428 2/20 0.43
LMNA P02545 1/20 0.43
MTOR P42345 8/20 0.42
PIK3CD O00329 1/20 0.42
PIK3CB P42338 1/20 0.42
PIK3CG P48736 1/20 0.42
PRKDC P78527 1/20 0.42
PIK3C3 Q8NEB9 1/20 0.42
NPC1 O15118 1/20 0.42
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PKM P14618 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4192343 0.92 ALDH1A1 (0.47) ALDH1A1POLBCLK1HPGDLMNA
SCHEMBL4192347 0.89 ALDH1A1 (0.42) ALDH1A1CLK1HPGDLMNANPC1
SCHEMBL4190737 0.88 ALDH1A1 (0.43) ALDH1A1POLBCLK1HPGDLMNA
SCHEMBL4194915 0.87 ALDH1A1 (0.44) ALDH1A1POLBCLK1HPGDLMNA
SCHEMBL4186018 0.86 ALDH1A1 (0.43) ALDH1A1POLBAKT1PIK3CAHPGD
SCHEMBL4197657 0.86 ALDH1A1 (0.44) ALDH1A1AKT1PIK3CAHPGDLMNA
SCHEMBL4193911 0.85 ALDH1A1 (0.43) ALDH1A1POLBCLK1HPGDLMNA
SCHEMBL4194631 0.82 ALDH1A1 (0.46) ALDH1A1AKT1PIK3CAHPGDLMNA
SCHEMBL4197354 0.82 KDM4E (0.49) ALDH1A1LMNAHSD17B10PKMMEN1
SCHEMBL4192474 0.81 MAPT (0.48) ALDH1A1POLBLMNAHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 ALDH1A1 2744/4885POLB 215/4885CLK1 4195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.